SIGNATUREFD, LLC CRNX — CRINETICS PHARMACEUTICALS IN

Ownership history in SIGNATUREFD, LLC  ·  22 quarters on record

AI Ownership Summary

SIGNATUREFD, LLC reported CRINETICS PHARMACEUTICALS IN (CRNX) in 22 quarterly 13F filings from 2023 Q4 through 2026 Q1. The latest visible filing shows CRNX at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CRNX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SIGNATUREFD, LLC's position in CRINETICS PHARMACEUTICALS IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CRNX was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CRNX stock page SIGNATUREFD, LLC fund profile SIGNATUREFD, LLC full holdings
How SIGNATUREFD, LLC held CRNX — position size vs. price
% of Fund (quarterly)    CRNX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 510 -4 -0.8% 0.00% $19K 2026-04-07 $38.41
2025 Q4 ADDED — — — 514 +126 +32.5% 0.00% $24K 2026-01-20 $55.69
2025 Q3 ADDED — — — 388 +91 +30.6% 0.00% $16K 2025-10-21 $42.85
2025 Q2 REDUCED 18.0% +51.3% ❌ 297 -65 -18.0% 0.00% $9K 2025-07-16 $31.90
2025 Q1 REDUCED 24.4% -14.2% ✅ 362 -117 -24.4% 0.00% $12K 2025-05-02 $33.76
2024 Q4 UNCHANGED — — — 479 — 0% 0.00% $24K 2025-02-10 $36.53
2024 Q3 UNCHANGED — — — 479 — 0% 0.00% $24K 2024-10-21 $58.70
2024 Q2 ADDED — — — 479 +174 +57.0% 0.00% $21K 2024-07-29 $54.26
2024 Q1 ADDED — — — 305 +4 +1.3% 0.00% $14K 2024-05-03 $47.20
2023 Q4 REDUCED 39.9% +30.8% ❌ 301 -200 -39.9% 0.00% $11K 2024-02-01 $37.21
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding CRNX

As of 2026 Q1 — sorted by position size

MOODY ALDRICH PARTNERS LLC 3Y 7Y 1.2% BRAUN STACEY ASSOCIATES INC 3Y 7Y 0.39% Lewis Asset Management, LLC 0.39% PSP Research LLC 0.28% Candriam S.C.A. 3Y 7Y 0.16% SANDERS MORRIS HARRIS LLC 3Y 7Y 0.12% Pictet Asset Management Holding SA 0.07% China Universal Asset Management Co., Ltd. 3Y 0.05% Aberdeen Group plc 3Y 7Y 0.05% Bayforest Capital Ltd 0.04%

FAQ About SIGNATUREFD, LLC and CRNX

These are the practical questions this page is built to answer before you even open the full history table.

How long has SIGNATUREFD, LLC reported owning CRNX?

SIGNATUREFD, LLC reported CRNX across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported CRNX position in SIGNATUREFD, LLC's portfolio?

The largest reported portfolio weight for CRNX was 0.00% in 2024 Q3.

What is the latest reported CRNX position on this page?

The most recent filing on this page is 2026 Q1, when SIGNATUREFD, LLC reported 510 shares, equal to 0.00% of portfolio, with an estimated market value of $19K.

What does the chart on this CRNX ownership page compare?

The chart compares SIGNATUREFD, LLC's quarterly CRNX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did SIGNATUREFD, LLC time their CRNX position?

Based on 13F filing dates vs. subsequent CRNX price moves, SIGNATUREFD, LLC correctly timed 7 out of 15 reported position changes (47%). The annualised alpha on CRNX relative to SPY over the holding period was +4.1%.

← Back to SIGNATUREFD, LLC Holdings